FCER2 and B-cell chronic lymphocytic leukemia: Chronic lymphocytic leukemia (CLL) is the most prevalent lymphoproliferative disorder in the United States and Europe and is characterized by the clonal expansion of mature CD5+ CD23+ B cells  (1, 2).